Clinical Trial Applications: Filter, Search, and view applications
# | Protocol No | Study Title | Investigator(s) & Site(s) | |
---|---|---|---|---|
171. |
ECCT/21/07/01 | RESOLVE A Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell DiseaseA Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy of Voxelotor for the Treatment of Leg Ulcers in Patients with Sickle Cell Disease |
Principal Investigator(s) 1. Bernhards Ragama Ogutu 2. Jessie Nyokabi Githanga Site(s) in Kenya 1. Strathmore University Medical Center (Nairobi City county) 2. KEMRI Kondele children\'S Hospital (Kisumu county) 3. Gertrude\'s Children\'s Hospital (Nairobi City county) |
View |
172. |
ECCT/21/06/15 | Therapeutic Efficacy Study Efficacy of Artemether Lumefantrine (AL) and Dihydroartemisinin-Piperaquine (DHP) for the treatment of uncomplicated Plasmodium falciparum malaria in Siaya and Bungoma counties, Kenya. |
Principal Investigator(s) 1. Dr. Sarah-Blythe Ballard 2. Dr. Willis Akhwale 3. Dr. Grace Ikahu 4. Dr. George Githuka 5. Dr. Dickson Mtungu Mwakangalu 6. Dr. Elvis Omondi Oyugi 7. Hellen Gatakaa 8. Regina Jepkosgei Kandie 9. Dr. Fredrick Ouma Odhiambo Site(s) in Kenya 1. Mahonge Health Center (Bung\'oma county) 2. Kaluo Health Center (Siaya county) |
View |
173. |
ECCT/21/06/14 | CoVPN 3008 Multi-Center, Randomized, Efficacy Study of COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern |
Principal Investigator(s) 1. Abraham Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI Kisumu Clinical Research Site (Kisumu county) |
View |
174. |
ECCT/21/06/13 | CARES A Phase 3b, Randomized, Multicenter, Open-Label Study Evaluating the Efficacy, Safety, and Tolerability of Switching to Long-Acting Cabotegravir Plus Long-Acting Rilpivirine From Current Antiretroviral Regimen in HIV-1 Infected, Virologically Suppressed Adults in Sub-Saharan Africa |
Principal Investigator(s) 1. Abraham Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI Walter Reed Project (Kericho county) 3. Aga khan University Hospital (Nairobi City county) |
View |
175. |
ECCT/21/06/12 | VAT00008 A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older |
Principal Investigator(s) 1. Abraham Siika Site(s) in Kenya 1. Moi University Clinical Research Centre (Uasin Gishu county) 2. KEMRI/Walter Reed Project Research Center (Kericho county) 3. Kenya Medical Research Institute (Kisumu county) 4. Ganjoni Clinic (Mombasa county) 5. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county) 6. Kenya Medical Research Institute (Nairobi City county) 7. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 8. Aga Khan University Hospital (Nairobi City county) 9. KEMRI CCR-Butere County Hospital Site (Bung\'oma county) |
View |